These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Role of mesenchymal stem cell therapy in Crohn's disease. Dalal J; Gandy K; Domen J Pediatr Res; 2012 Apr; 71(4 Pt 2):445-51. PubMed ID: 22430380 [TBL] [Abstract][Full Text] [Related]
8. Remestemcel-L, the first cellular therapy product for the treatment of graft-versus-host disease. Daly A Drugs Today (Barc); 2012 Dec; 48(12):773-83. PubMed ID: 23243634 [TBL] [Abstract][Full Text] [Related]
9. Advances in mesenchymal stromal cell therapy in the management of Crohn's disease. Ibraheim H; Giacomini C; Kassam Z; Dazzi F; Powell N Expert Rev Gastroenterol Hepatol; 2018 Feb; 12(2):141-153. PubMed ID: 29096549 [TBL] [Abstract][Full Text] [Related]
10. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124 [TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic applications of mesenchymal stromal cells. Larsen S; Lewis ID Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Prasad VK; Lucas KG; Kleiner GI; Talano JA; Jacobsohn D; Broadwater G; Monroy R; Kurtzberg J Biol Blood Marrow Transplant; 2011 Apr; 17(4):534-41. PubMed ID: 20457269 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis. Cao Y; Ding Z; Han C; Shi H; Cui L; Lin R Dig Dis Sci; 2017 Apr; 62(4):851-860. PubMed ID: 28168575 [TBL] [Abstract][Full Text] [Related]
16. A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease. Kurtzberg J; Abdel-Azim H; Carpenter P; Chaudhury S; Horn B; Mahadeo K; Nemecek E; Neudorf S; Prasad V; Prockop S; Quigg T; Satwani P; Cheng A; Burke E; Hayes J; Skerrett D; Biol Blood Marrow Transplant; 2020 May; 26(5):845-854. PubMed ID: 32018062 [TBL] [Abstract][Full Text] [Related]
17. The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Galipeau J Cytotherapy; 2013 Jan; 15(1):2-8. PubMed ID: 23260081 [TBL] [Abstract][Full Text] [Related]
18. Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn's disease. Ferrer L; Kimbrel EA; Lam A; Falk EB; Zewe C; Juopperi T; Lanza R; Hoffman A Regen Med; 2016 Jan; 11(1):33-43. PubMed ID: 26387424 [TBL] [Abstract][Full Text] [Related]